These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2131761)

  • 1. [In vitro evaluation of antimicrobial activity of fusafungine].
    German-Fattal M; German A
    Ann Pharm Fr; 1990; 48(6):295-305. PubMed ID: 2131761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fusafungine on adherence of Haemophilus influenzae type b to human epithelial cells in vitro.
    Karam-Sarkis D; German-Fattal M; Bourlioux P
    Biomed Pharmacother; 1991; 45(7):301-6. PubMed ID: 1760521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current data on the antimicrobial spectrum of fusafungin].
    German-Fattal M
    Ann Otolaryngol Chir Cervicofac; 1994; 111(1):43-6. PubMed ID: 7998756
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioassay-guided isolation and evaluation of antimicrobial compounds from Ixora megalophylla against some oral pathogens.
    Panyo J; Matsunami K; Panichayupakaranant P
    Pharm Biol; 2016 Sep; 54(9):1522-7. PubMed ID: 26809027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antimicrobial potential of 10% ginger extract against Streptococcus mutans, Candida albicans, and Enterococcus faecalis: an in vitro study.
    Giriraju A; Yunus GY
    Indian J Dent Res; 2013; 24(4):397-400. PubMed ID: 24047828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiadherent activity of Schinus terebinthifolius and Croton urucurana extracts on in vitro biofilm formation of Candida albicans and Streptococcus mutans.
    Barbieri DS; Tonial F; Lopez PV; Sales Maia BH; Santos GD; Ribas MO; Glienke C; Vicente VA
    Arch Oral Biol; 2014 Sep; 59(9):887-96. PubMed ID: 24907518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae.
    Ikejima H; Yamamoto H; Ishida K; Terakubo S; Kaku M; Shimada J
    J Infect Chemother; 2001 Jun; 7(2):121-3. PubMed ID: 11455504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkali cation transport through liposomes by the antimicrobial fusafungine and its constitutive enniatins.
    Levy D; Bluzat A; Seigneuret M; Rigaud JL
    Biochem Pharmacol; 1995 Dec; 50(12):2105-7. PubMed ID: 8849339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.
    Liu Y; Wang L; Zhou X; Hu S; Zhang S; Wu H
    Int J Antimicrob Agents; 2011 Jan; 37(1):33-8. PubMed ID: 20956070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro.
    Hannan PC
    J Med Microbiol; 1998 Dec; 47(12):1115-22. PubMed ID: 9856648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of fusafungine during experimentally induced rhinosinusitis in the rabbit.
    Otori N; Paydas G; Stierna P; Westrin KM
    Eur Arch Otorhinolaryngol; 1998; 255(4):195-201. PubMed ID: 9592677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decade-long use of the antimicrobial peptide combination tyrothricin does not pose a major risk of acquired resistance with gram-positive bacteria and Candida spp.
    Stauss-Grabo M; Atiye S; Le T; Kretschmar M
    Pharmazie; 2014 Nov; 69(11):838-41. PubMed ID: 25985581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of tigecycline against clinical isolates from Shanghai, China.
    Zhang YY; Zhou L; Zhu DM; Wu PC; Hu FP; Wu WH; Wang F
    Diagn Microbiol Infect Dis; 2004 Dec; 50(4):267-81. PubMed ID: 15582300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
    Kays MB; Lisek CR; Denys GA
    Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and antifungal activities of 2,3-pyrrolidinedione derivatives against oral pathogens.
    Dhavan AA; Ionescu AC; Kaduskar RD; Brambilla E; Dallavalle S; Varoni EM; Iriti M
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1376-80. PubMed ID: 26860735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An
    Niska K; Knap N; Kędzia A; Jaskiewicz M; Kamysz W; Inkielewicz-Stepniak I
    Int J Med Sci; 2016; 13(10):772-782. PubMed ID: 27766027
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of essential oils from mint in Senegal].
    Sow AI; Koyalta D; Boye CS; Diedhiou/Badiane D; Bassene E
    Dakar Med; 1995; 40(2):193-5. PubMed ID: 10602687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.